BriaCell's Phase 2 analyses presented at #AACR26 identify mitotic circulating tumor cells and PD-L1 expression in tumor-macrophage fusion cells as potential prognostic biomarkers in #metastaticbreastcancer. Learn more: https://t.co/3iv2NhV050

$BCTX $BCTXL https://t.co/ENjcYbVYoT